⌘K

Login Start Free

Home/Filings/4/0001264931-15-000025

4//SEC Filing

Immune Therapeutics, Inc. 4

Accession 0001264931-15-000025

CIK 0001559356operating

View on SEC.gov Company Profile

Filed

Jan 15, 7:00 PM ET

Accepted

Jan 16, 10:43 AM ET

Size

5.2 KB

Accession

0001264931-15-000025

Insider Transaction Report

Form 4

Period: 2015-01-15

Immune Therapeutics, Inc.IMUN

CHIEF FINANCIAL OFFICER

Transactions

Award
WARRANT (RIGHT TO BUY)
2015-01-15+250,000→ 250,000 total
Exercise: $0.14From: 2014-12-15Exp: 2019-12-14→ COMMON STOCK (250,000 underlying)

Documents

1 file

4
peteraronstamform4.xmlPrimary
OWNERSHIP DOCUMENT

Issuer

Immune Therapeutics, Inc.

CIK 0001559356

Entity typeoperating

IncorporatedFL

Related Parties

1

filerCIK 0001559356

Filing Metadata

Form type: 4
Filed: Jan 15, 7:00 PM ET
Accepted: Jan 16, 10:43 AM ET
Size: 5.2 KB

View on SEC.gov